Archives: Search / 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015
2007 Archives
Company to Launch Product Immediately Philadelphia, PA – December 12, 2007 – Lannett Company, Inc. (Amex: LCI) today announced it has received approval from the U.S. Food and Drug Administration (FDA) for the company’s... More |
Philadelphia, PA – August 1, 2008 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approvals from the U.S. Food and... More |
Philadelphia, PA – May 15, 2008 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, said today that it continues to work closely with the U.S. Food and Drug... More |
Lannett Company, Inc. (Amex: LCI) today announced that Larry Dalesandro, its Chief Financial Officer (CFO), has resigned effective December 1, 2004 for personal reasons. Lannett has appointed... More |
Philadelphia, PA – June 2, 2010 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that Arthur Bedrosian, president and chief executive officer, will present a company overview... More |
PHILADELPHIA, PA – November 16, 2004 – LANNETT ® COMPANY, INC. (AMEX: LCInews), a manufacturer of generic pharmaceuticals, is pleased to announce the launch of three new drug... More |